COlchicine for the Prevention of Post Electrical Cardioversion Recurrence of AF

NCT02582190 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Investigational Medicinal Product Supplies

Conditions

Atrial Fibrillation

Interventions

DRUG: Colchicine group

Sponsor

Elpen Pharmaceutical Co. Inc.